Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Esophagus Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02394548
What this trial is testing

Phase I Trial Of IMRT Using A Contralateral Esophagus Sparing Technique (CEST) In Locally Advanced Lung Cancer

Who this might be right for
Non-small Cell Lung CarcinomaSmall Cell Lung Carcinoma
Massachusetts General Hospital 27
Very early researchEnrolling By InvitationNCT07371247
What this trial is testing

Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and Efficacy

Who this might be right for
Esophageal CancerMRDctDNA
The First Affiliated Hospital with Nanjing Medical University 65
Early research (Phase 1)Looking for participantsNCT06910657
What this trial is testing

IDOV-Immune for Advanced Solid Tumors

Who this might be right for
Colorectal CancerPancreatic CancerMelanoma+13 more
ViroMissile, Inc. 78
Early research (Phase 1)Study completedNCT00003427
What this trial is testing

Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer

Who this might be right for
Anal CancerColorectal CancerEsophageal Cancer+7 more
Memorial Sloan Kettering Cancer Center 36
Early research (Phase 1)Ended earlyNCT00524186
What this trial is testing

Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Roswell Park Cancer Institute 23
Early research (Phase 1)Study completedNCT03199586
What this trial is testing

Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies

Who this might be right for
Breast CancerPancreas CancerProstate Cancer+6 more
Novita Pharmaceuticals, Inc. 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT04229459
What this trial is testing

Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients.

Who this might be right for
Esophageal Squamous Cell Carcinoma
Baruch Brenner 12
Testing effectiveness (Phase 2)Study completedNCT03365791
What this trial is testing

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

Who this might be right for
Small Cell Lung CancerGastric AdenocarcinomaEsophageal Adenocarcinoma+5 more
Novartis Pharmaceuticals 76
Early research (Phase 1)UnknownNCT06205082
What this trial is testing

A Phase I Clinical Trial to Evaluate LIT-00814 Tablets in Patients With Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
LittDD Medicines Ltd 81
Not applicableLooking for participantsNCT07375420
What this trial is testing

Will a Pre-therapy Exercise Intervention Improve the Outcomes of Patients With Advanced Oesophageal Cancer?

Who this might be right for
Oesophageal AdenocarcinomaT CellsTumor Microenvironment+1 more
University of Surrey 50
Early research (Phase 1)Active Not RecruitingNCT05215574
What this trial is testing

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerBreast CancerGastric Cancer+13 more
NGM Biopharmaceuticals, Inc 130
Testing effectiveness (Phase 2)Study completedNCT02001623
What this trial is testing

Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors

Who this might be right for
Ovary CancerCervix CancerEndometrium Cancer+5 more
Seagen Inc. 195
Early research (Phase 1)Study completedNCT01051479
What this trial is testing

A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Wake Forest University Health Sciences 22
Early research (Phase 1)Study completedNCT00313599
What this trial is testing

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsBreast Cancer+6 more
University of California, San Francisco 28
Not applicableStudy completedNCT05697198
What this trial is testing

PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine

Who this might be right for
Lung CancerOvarian CancerUterine Cancer+10 more
Labcorp Corporation of America Holdings, Inc 1,429
Testing effectiveness (Phase 2)Study completedNCT00213486
What this trial is testing

Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial

Who this might be right for
Esophageal Neoplasms
University Hospital, Rouen 43
Testing effectiveness (Phase 2)UnknownNCT03985670
What this trial is testing

Teripalimab Plus Chemotherapy in Local Advanced Esophageal Cancer

Who this might be right for
Squamous Cell CarcinomaEsophageal CancerPerioperative Period
Henan Cancer Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00051480
What this trial is testing

Study of TNFerade™ Gene Therapy, Radiation, 5-FU and Cisplatin in Esophageal Cancer

Who this might be right for
Esophageal Cancer
GenVec
Large-scale testing (Phase 3)Looking for participantsNCT05357846
What this trial is testing

PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)

Who this might be right for
Squamous Cell Esophageal CarcinomaEsophageal CancerOesophageal Cancer
Sun Yat-sen University 422
Early research (Phase 1)Study completedNCT00019513
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas

Who this might be right for
Colorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Next Page